Physician profile
Nirav A Patel
NPI 1790907418
$12,403.67
in general payments reported to CMS, 2019-2025
27 companies · $3,313 in 2025
The $3,313 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,136 · 2020: $304 · 2021: $1,154 · 2022: $910 · 2023: $3,724 · 2024: $1,863 · 2025: $3,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,165 · Food and Beverage: $1,979 · Travel and Lodging: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,165.00 |
| Food and Beverage | $1,978.70 |
| Travel and Lodging | $756.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $7,903.22 | 2022-2025 | Eliquis, Camzyos |
| Angiodynamics, INC. | $1,020.52 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $798.18 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Reliance 4-Front |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $728.56 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $310.40 | 2019-2023 | Xarelto |
| Abbott Laboratories | $215.88 | 2019-2024 | Navitor |
| Biotronik INC. | $193.76 | 2022 | |
| Veryan Medical Incorporated | $152.15 | 2021-2022 | |
| Pfizer INC. | $139.75 | 2021-2025 | |
| Amgen INC. | $124.98 | 2021-2024 | Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $116.80 | 2019 | |
| Abiomed | $110.32 | 2019-2025 | |
| Cvrx, INC. | $109.94 | 2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $82.45 | 2020-2024 | |
| Medtronic Vascular, INC. | $79.70 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intact Vascular, INC. | $45.08 | 2019 | |
| Cardiovascular Systems INC. | $43.75 | 2020 | |
| Merck Sharp & Dohme LLC | $40.45 | 2021-2022 | |
| Nuwellis, INC. | $29.37 | 2019-2024 | Aquadex Smartflow Console |
| Mallinckrodt Hospital Products INC. | $29.24 | 2024 | Acthar |
| Inspire Medical Systems, INC. | $27.25 | 2025 | Inspire |
| Medtronic, INC. | $23.99 | 2025 | Corevalve Evolut R |
| Tactile Systems Technology INC | $21.28 | 2025 | Nimbl, Flexitouch Plus |
| Elutia, INC. | $15.56 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.97 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.